nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Sorafenib—liver cancer	0.218	0.28	CbGbCtD
Halofantrine—CYP2C8—Sorafenib—liver cancer	0.21	0.269	CbGbCtD
Halofantrine—CYP2D6—Sorafenib—liver cancer	0.134	0.172	CbGbCtD
Halofantrine—CYP3A4—Sorafenib—liver cancer	0.0851	0.109	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—liver cancer	0.0812	0.104	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—liver cancer	0.0516	0.0662	CbGbCtD
Halofantrine—Hypertensive crisis—Sorafenib—liver cancer	0.0148	0.146	CcSEcCtD
Halofantrine—Stomatitis—Sorafenib—liver cancer	0.00225	0.022	CcSEcCtD
Halofantrine—Tinnitus—Sorafenib—liver cancer	0.00193	0.0189	CcSEcCtD
Halofantrine—Rigors—Epirubicin—liver cancer	0.00187	0.0183	CcSEcCtD
Halofantrine—Arrhythmia—Sorafenib—liver cancer	0.00185	0.0181	CcSEcCtD
Halofantrine—Rigors—Doxorubicin—liver cancer	0.00173	0.0169	CcSEcCtD
Halofantrine—Cough—Sorafenib—liver cancer	0.00157	0.0154	CcSEcCtD
Halofantrine—Arthralgia—Sorafenib—liver cancer	0.00153	0.015	CcSEcCtD
Halofantrine—Myalgia—Sorafenib—liver cancer	0.00153	0.015	CcSEcCtD
Halofantrine—Anaphylactic shock—Sorafenib—liver cancer	0.00147	0.0144	CcSEcCtD
Halofantrine—Anorexia—Sorafenib—liver cancer	0.0014	0.0137	CcSEcCtD
Halofantrine—Pulmonary oedema—Epirubicin—liver cancer	0.00136	0.0133	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00134	0.0131	CcSEcCtD
Halofantrine—Abnormal vision—Epirubicin—liver cancer	0.00133	0.013	CcSEcCtD
Halofantrine—Dyspepsia—Sorafenib—liver cancer	0.00129	0.0127	CcSEcCtD
Halofantrine—Decreased appetite—Sorafenib—liver cancer	0.00128	0.0125	CcSEcCtD
Halofantrine—Fatigue—Sorafenib—liver cancer	0.00127	0.0124	CcSEcCtD
Halofantrine—Constipation—Sorafenib—liver cancer	0.00126	0.0123	CcSEcCtD
Halofantrine—Pulmonary oedema—Doxorubicin—liver cancer	0.00125	0.0123	CcSEcCtD
Halofantrine—Abnormal vision—Doxorubicin—liver cancer	0.00123	0.0121	CcSEcCtD
Halofantrine—Gastrointestinal pain—Sorafenib—liver cancer	0.0012	0.0118	CcSEcCtD
Halofantrine—Urticaria—Sorafenib—liver cancer	0.00117	0.0115	CcSEcCtD
Halofantrine—Abdominal pain—Sorafenib—liver cancer	0.00116	0.0114	CcSEcCtD
Halofantrine—Cerebrovascular accident—Epirubicin—liver cancer	0.00113	0.0111	CcSEcCtD
Halofantrine—Face oedema—Epirubicin—liver cancer	0.00107	0.0105	CcSEcCtD
Halofantrine—Asthenia—Sorafenib—liver cancer	0.00105	0.0103	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00104	0.0102	CcSEcCtD
Halofantrine—Pruritus—Sorafenib—liver cancer	0.00104	0.0102	CcSEcCtD
Halofantrine—Orthostatic hypotension—Epirubicin—liver cancer	0.00101	0.0099	CcSEcCtD
Halofantrine—Diarrhoea—Sorafenib—liver cancer	0.00101	0.00987	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—liver cancer	0.000988	0.00968	CcSEcCtD
Halofantrine—Dizziness—Sorafenib—liver cancer	0.000972	0.00953	CcSEcCtD
Halofantrine—Abdominal distension—Epirubicin—liver cancer	0.000962	0.00943	CcSEcCtD
Halofantrine—Vomiting—Sorafenib—liver cancer	0.000935	0.00917	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000934	0.00916	CcSEcCtD
Halofantrine—Rash—Sorafenib—liver cancer	0.000927	0.00909	CcSEcCtD
Halofantrine—Dermatitis—Sorafenib—liver cancer	0.000926	0.00908	CcSEcCtD
Halofantrine—Headache—Sorafenib—liver cancer	0.000921	0.00903	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—liver cancer	0.00089	0.00873	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—liver cancer	0.000883	0.00866	CcSEcCtD
Halofantrine—Nausea—Sorafenib—liver cancer	0.000873	0.00856	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—liver cancer	0.00083	0.00814	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—liver cancer	0.000817	0.00801	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—liver cancer	0.000768	0.00754	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—liver cancer	0.000737	0.00723	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—liver cancer	0.000713	0.00699	CcSEcCtD
Halofantrine—Chills—Epirubicin—liver cancer	0.000686	0.00673	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—liver cancer	0.000683	0.0067	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—liver cancer	0.000682	0.00669	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—liver cancer	0.00066	0.00647	CcSEcCtD
Halofantrine—Back pain—Epirubicin—liver cancer	0.000644	0.00632	CcSEcCtD
Halofantrine—Chills—Doxorubicin—liver cancer	0.000635	0.00623	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—liver cancer	0.000632	0.0062	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—liver cancer	0.000618	0.00606	CcSEcCtD
Halofantrine—Malaise—Epirubicin—liver cancer	0.0006	0.00589	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—liver cancer	0.000596	0.00584	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—liver cancer	0.000588	0.00577	CcSEcCtD
Halofantrine—Cough—Epirubicin—liver cancer	0.000581	0.0057	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—liver cancer	0.000577	0.00566	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—liver cancer	0.000572	0.00561	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—liver cancer	0.000567	0.00556	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—liver cancer	0.000567	0.00556	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—liver cancer	0.000567	0.00556	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—liver cancer	0.00056	0.00549	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—liver cancer	0.000556	0.00545	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—liver cancer	0.000548	0.00537	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—liver cancer	0.000544	0.00534	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—liver cancer	0.000543	0.00533	CcSEcCtD
Halofantrine—Cough—Doxorubicin—liver cancer	0.000538	0.00527	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—liver cancer	0.000534	0.00523	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—liver cancer	0.000524	0.00514	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—liver cancer	0.000524	0.00514	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—liver cancer	0.000524	0.00514	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—liver cancer	0.000518	0.00508	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—liver cancer	0.000518	0.00508	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—liver cancer	0.000507	0.00497	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—liver cancer	0.000503	0.00493	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000495	0.00485	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—liver cancer	0.000488	0.00478	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—liver cancer	0.000479	0.0047	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—liver cancer	0.000478	0.00469	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—liver cancer	0.000472	0.00463	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—liver cancer	0.000468	0.00459	CcSEcCtD
Halofantrine—Constipation—Epirubicin—liver cancer	0.000465	0.00456	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000458	0.00449	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—liver cancer	0.000451	0.00443	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—liver cancer	0.000448	0.00439	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—liver cancer	0.000444	0.00436	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—liver cancer	0.000443	0.00434	CcSEcCtD
Halofantrine—CYP3A5—Biological oxidations—GSTA1—liver cancer	0.00044	0.0037	CbGpPWpGaD
Halofantrine—Decreased appetite—Doxorubicin—liver cancer	0.000437	0.00429	CcSEcCtD
Halofantrine—CYP2C8—Metapathway biotransformation—GSTA3—liver cancer	0.000437	0.00368	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—NAT2—liver cancer	0.000435	0.00366	CbGpPWpGaD
Halofantrine—Fatigue—Doxorubicin—liver cancer	0.000433	0.00425	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—liver cancer	0.000432	0.00423	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—liver cancer	0.00043	0.00422	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—liver cancer	0.00043	0.00421	CcSEcCtD
Halofantrine—CYP3A5—Metapathway biotransformation—NAT2—liver cancer	0.000429	0.00361	CbGpPWpGaD
Halofantrine—Feeling abnormal—Doxorubicin—liver cancer	0.000414	0.00406	CcSEcCtD
Halofantrine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000414	0.00349	CbGpPWpGaD
Halofantrine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000411	0.00403	CcSEcCtD
Halofantrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000409	0.00345	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GSTA4—liver cancer	0.000405	0.00341	CbGpPWpGaD
Halofantrine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000404	0.0034	CbGpPWpGaD
Halofantrine—Urticaria—Doxorubicin—liver cancer	0.000399	0.00392	CcSEcCtD
Halofantrine—CYP2C8—Metapathway biotransformation—GSTA4—liver cancer	0.000399	0.00337	CbGpPWpGaD
Halofantrine—Abdominal pain—Doxorubicin—liver cancer	0.000397	0.0039	CcSEcCtD
Halofantrine—CYP2C8—Biological oxidations—GSTA2—liver cancer	0.000395	0.00333	CbGpPWpGaD
Halofantrine—Asthenia—Epirubicin—liver cancer	0.00039	0.00382	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—liver cancer	0.000384	0.00377	CcSEcCtD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000383	0.00323	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GSTA1—liver cancer	0.000381	0.00321	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000379	0.0032	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000378	0.00319	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—NAT2—liver cancer	0.000376	0.00317	CbGpPWpGaD
Halofantrine—Diarrhoea—Epirubicin—liver cancer	0.000372	0.00365	CcSEcCtD
Halofantrine—CYP2C8—Metapathway biotransformation—NAT2—liver cancer	0.000371	0.00313	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.00037	0.00312	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—GPX3—liver cancer	0.000364	0.00307	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000363	0.00306	CbGpPWpGaD
Halofantrine—Asthenia—Doxorubicin—liver cancer	0.000361	0.00354	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—liver cancer	0.000359	0.00352	CcSEcCtD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000358	0.00302	CbGpPWpGaD
Halofantrine—Pruritus—Doxorubicin—liver cancer	0.000356	0.00349	CcSEcCtD
Halofantrine—CYP3A5—Biological oxidations—HPGDS—liver cancer	0.000347	0.00293	CbGpPWpGaD
Halofantrine—Vomiting—Epirubicin—liver cancer	0.000345	0.00339	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—liver cancer	0.000344	0.00337	CcSEcCtD
Halofantrine—Rash—Epirubicin—liver cancer	0.000343	0.00336	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—liver cancer	0.000342	0.00336	CcSEcCtD
Halofantrine—Headache—Epirubicin—liver cancer	0.00034	0.00334	CcSEcCtD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000336	0.00283	CbGpPWpGaD
Halofantrine—Dizziness—Doxorubicin—liver cancer	0.000332	0.00326	CcSEcCtD
Halofantrine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000332	0.0028	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000332	0.0028	CbGpPWpGaD
Halofantrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000332	0.00279	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000328	0.00276	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000324	0.00273	CbGpPWpGaD
Halofantrine—Nausea—Epirubicin—liver cancer	0.000323	0.00317	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—liver cancer	0.00032	0.00313	CcSEcCtD
Halofantrine—Rash—Doxorubicin—liver cancer	0.000317	0.00311	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—liver cancer	0.000317	0.00311	CcSEcCtD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000317	0.00267	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—GPX3—liver cancer	0.000316	0.00266	CbGpPWpGaD
Halofantrine—Headache—Doxorubicin—liver cancer	0.000315	0.00309	CcSEcCtD
Halofantrine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000313	0.00263	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000309	0.0026	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000306	0.00258	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000305	0.00257	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000302	0.00254	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—HPGDS—liver cancer	0.000301	0.00254	CbGpPWpGaD
Halofantrine—Nausea—Doxorubicin—liver cancer	0.000299	0.00293	CcSEcCtD
Halofantrine—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000283	0.00239	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	0.000279	0.00235	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000278	0.00235	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000272	0.0023	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000272	0.00229	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000269	0.00227	CbGpPWpGaD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000262	0.0022	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—JUN—liver cancer	0.000261	0.0022	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—GGT1—liver cancer	0.00026	0.00219	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000259	0.00218	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000259	0.00218	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000248	0.00209	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000247	0.00208	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP2E1—liver cancer	0.000245	0.00207	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP2E1—liver cancer	0.000242	0.00204	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000242	0.00204	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000238	0.002	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000234	0.00198	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—GSTP1—liver cancer	0.000234	0.00197	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	0.00023	0.00194	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000228	0.00192	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GGT1—liver cancer	0.000225	0.0019	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—BRAF—liver cancer	0.000225	0.0019	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00022	0.00185	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000217	0.00183	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000217	0.00183	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—GSTM1—liver cancer	0.000215	0.00181	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000214	0.00181	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000212	0.00178	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	0.000212	0.00178	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000204	0.00172	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP1A1—liver cancer	0.000203	0.00171	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GSTP1—liver cancer	0.000202	0.00171	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000202	0.0017	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000201	0.0017	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	0.000201	0.00169	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—GSTP1—liver cancer	0.0002	0.00168	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000199	0.00168	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000199	0.00167	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—TNF—liver cancer	0.000196	0.00165	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—RAF1—liver cancer	0.000188	0.00158	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GSTM1—liver cancer	0.000186	0.00157	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000185	0.00156	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—GSTM1—liver cancer	0.000183	0.00155	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000179	0.00151	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000178	0.0015	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP1A1—liver cancer	0.000176	0.00149	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP1A1—liver cancer	0.000174	0.00146	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000173	0.00146	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000169	0.00143	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000166	0.0014	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000164	0.00138	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000162	0.00136	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL6—liver cancer	0.000158	0.00133	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000153	0.00129	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—UGDH—liver cancer	0.000152	0.00128	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000151	0.00127	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000145	0.00122	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—EPT1—liver cancer	0.000143	0.00121	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000143	0.0012	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TAT—liver cancer	0.000136	0.00114	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000132	0.00111	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—UGDH—liver cancer	0.000132	0.00111	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000132	0.00111	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00013	0.00109	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—EPT1—liver cancer	0.000124	0.00104	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000121	0.00102	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TAT—liver cancer	0.000117	0.00099	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000116	0.000974	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000109	0.000915	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—UGDH—liver cancer	0.000108	0.000912	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000107	0.000903	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—HRAS—liver cancer	0.000104	0.000873	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—EPT1—liver cancer	0.000102	0.000858	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.98e-05	0.000841	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	9.84e-05	0.000829	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TAT—liver cancer	9.65e-05	0.000813	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	9.46e-05	0.000797	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	9.33e-05	0.000786	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CPT1B—liver cancer	9.22e-05	0.000777	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GLUL—liver cancer	9.22e-05	0.000777	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NR1H4—liver cancer	8.89e-05	0.000749	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA3—liver cancer	8.74e-05	0.000737	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.65e-05	0.000729	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA4—liver cancer	8e-05	0.000674	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CPT1B—liver cancer	7.99e-05	0.000673	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GLUL—liver cancer	7.99e-05	0.000673	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA2—liver cancer	7.79e-05	0.000657	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NR1H4—liver cancer	7.7e-05	0.000649	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA3—liver cancer	7.57e-05	0.000638	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTA1—liver cancer	7.52e-05	0.000633	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NAT2—liver cancer	7.43e-05	0.000626	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALDOB—liver cancer	7.13e-05	0.000601	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—UGDH—liver cancer	7.08e-05	0.000596	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA4—liver cancer	6.93e-05	0.000584	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CRABP1—liver cancer	6.8e-05	0.000573	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.77e-05	0.00057	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA2—liver cancer	6.75e-05	0.000569	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—EPT1—liver cancer	6.65e-05	0.000561	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CPT1B—liver cancer	6.56e-05	0.000553	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GLUL—liver cancer	6.56e-05	0.000553	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTA1—liver cancer	6.51e-05	0.000549	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NAT2—liver cancer	6.44e-05	0.000543	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NR1H4—liver cancer	6.32e-05	0.000533	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TAT—liver cancer	6.31e-05	0.000531	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA3—liver cancer	6.22e-05	0.000524	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.19e-05	0.000522	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALDOB—liver cancer	6.17e-05	0.00052	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HPGDS—liver cancer	5.94e-05	0.000501	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CRABP1—liver cancer	5.89e-05	0.000496	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA4—liver cancer	5.69e-05	0.000479	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA2—liver cancer	5.54e-05	0.000467	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTA1—liver cancer	5.35e-05	0.00045	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.3e-05	0.000447	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PSMA4—liver cancer	5.3e-05	0.000446	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PSMD10—liver cancer	5.3e-05	0.000446	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NAT2—liver cancer	5.29e-05	0.000445	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GOT2—liver cancer	5.15e-05	0.000434	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HPGDS—liver cancer	5.15e-05	0.000434	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.12e-05	0.000431	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALDOB—liver cancer	5.07e-05	0.000427	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP2E1—liver cancer	4.84e-05	0.000408	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CRABP1—liver cancer	4.83e-05	0.000407	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.66e-05	0.000393	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.6e-05	0.000388	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PSMA4—liver cancer	4.59e-05	0.000387	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PSMD10—liver cancer	4.59e-05	0.000387	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYCS—liver cancer	4.53e-05	0.000382	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GOT2—liver cancer	4.46e-05	0.000376	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GGT1—liver cancer	4.45e-05	0.000375	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GOT1—liver cancer	4.45e-05	0.000375	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GLUL—liver cancer	4.29e-05	0.000361	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CPT1B—liver cancer	4.29e-05	0.000361	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HPGDS—liver cancer	4.23e-05	0.000356	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP2E1—liver cancer	4.2e-05	0.000354	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NR1H4—liver cancer	4.13e-05	0.000348	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA3—liver cancer	4.06e-05	0.000342	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.06e-05	0.000342	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTP1—liver cancer	3.99e-05	0.000337	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMOX1—liver cancer	3.94e-05	0.000332	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYCS—liver cancer	3.93e-05	0.000331	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GGT1—liver cancer	3.85e-05	0.000325	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GOT1—liver cancer	3.85e-05	0.000325	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PSMD10—liver cancer	3.77e-05	0.000317	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PSMA4—liver cancer	3.77e-05	0.000317	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA4—liver cancer	3.72e-05	0.000313	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—liver cancer	3.67e-05	0.000309	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GOT2—liver cancer	3.66e-05	0.000309	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA2—liver cancer	3.62e-05	0.000305	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTA1—liver cancer	3.49e-05	0.000295	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1A1—liver cancer	3.48e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTP1—liver cancer	3.46e-05	0.000292	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NAT2—liver cancer	3.46e-05	0.000291	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.44e-05	0.00029	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMOX1—liver cancer	3.41e-05	0.000288	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALDOB—liver cancer	3.31e-05	0.000279	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—liver cancer	3.24e-05	0.000273	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYCS—liver cancer	3.22e-05	0.000272	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARA—liver cancer	3.18e-05	0.000268	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—liver cancer	3.18e-05	0.000268	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GGT1—liver cancer	3.16e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GOT1—liver cancer	3.16e-05	0.000267	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CRABP1—liver cancer	3.16e-05	0.000266	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1A1—liver cancer	3.01e-05	0.000254	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTP1—liver cancer	2.84e-05	0.000239	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—liver cancer	2.81e-05	0.000237	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMOX1—liver cancer	2.8e-05	0.000236	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HPGDS—liver cancer	2.76e-05	0.000233	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARA—liver cancer	2.76e-05	0.000232	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CG—liver cancer	2.73e-05	0.00023	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARG—liver cancer	2.63e-05	0.000222	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—liver cancer	2.61e-05	0.00022	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.48e-05	0.000209	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.47e-05	0.000209	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PSMD10—liver cancer	2.46e-05	0.000207	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PSMA4—liver cancer	2.46e-05	0.000207	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CD—liver cancer	2.4e-05	0.000202	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GOT2—liver cancer	2.4e-05	0.000202	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—liver cancer	2.37e-05	0.000199	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CG—liver cancer	2.36e-05	0.000199	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—liver cancer	2.31e-05	0.000194	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARG—liver cancer	2.28e-05	0.000192	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARA—liver cancer	2.26e-05	0.000191	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.25e-05	0.00019	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYCS—liver cancer	2.11e-05	0.000178	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CB—liver cancer	2.09e-05	0.000176	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CD—liver cancer	2.08e-05	0.000175	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GGT1—liver cancer	2.07e-05	0.000174	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GOT1—liver cancer	2.07e-05	0.000174	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—liver cancer	2.05e-05	0.000173	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.94e-05	0.000163	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARG—liver cancer	1.87e-05	0.000158	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTP1—liver cancer	1.86e-05	0.000157	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMOX1—liver cancer	1.83e-05	0.000154	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CB—liver cancer	1.81e-05	0.000152	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—liver cancer	1.71e-05	0.000144	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.7e-05	0.000144	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—liver cancer	1.68e-05	0.000142	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.62e-05	0.000136	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—liver cancer	1.51e-05	0.000127	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.49e-05	0.000125	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARA—liver cancer	1.48e-05	0.000125	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CA—liver cancer	1.27e-05	0.000107	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.27e-05	0.000107	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARG—liver cancer	1.22e-05	0.000103	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.11e-05	9.39e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CA—liver cancer	1.1e-05	9.29e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—liver cancer	1.1e-05	9.27e-05	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—liver cancer	1.04e-05	8.77e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CB—liver cancer	9.71e-06	8.18e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CA—liver cancer	9.05e-06	7.63e-05	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—liver cancer	9.01e-06	7.59e-05	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—liver cancer	7.4e-06	6.23e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CA—liver cancer	5.92e-06	4.99e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—liver cancer	4.84e-06	4.08e-05	CbGpPWpGaD
